Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1998
The objectives of this study were to evaluate the efficacy, safety, and tolerability of pramipexole, as single-agent therapy or in combination with levodopa, in patients with Parkinson disease living in Hong Kong and Taiwan.
Epistemonikos ID: 232649c2f84b4a9ad6e09c62d540dd693fd88b22
First added on: May 11, 2024